Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Liu

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 4, 2019
In Reply to RyuEmma M Dunne, Mitchell Liu
Practical Radiation Oncology|June 28, 2024
In Regard to Moore-Palhares et alJee Suk Chang, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|January 10, 2021
Postoperative Stereotactic Body Radiation Therapy, Then ObserveEmma M Dunne, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|December 20, 2018
A Kidney Conundrum: More or Less?Emma M Dunne, Mitchell Liu
Journal of Applied Clinical Medical Physics|May 30, 2007
PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysisMiao Zhang, Vitali Moiseenko, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapyCarys Thomas, Mira Keyes, Mitchell Liu, et al.
Radiation Oncology (London, England)|June 23, 2017
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastasesRosanna Yeung, Jeremy Hamm, Mitchell Liu, et al.
Annals of Translational Medicine|August 15, 2018
Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directionsEmma Maria Dunne, Ian Mark Fraser, Mitchell Liu
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2026
Response to "Re: O'Reilly et al. On CTV utilization in non-spine bone oligometastases treated with SABR"Sarah Baker, Emily O'Reilly, Emma M Dunne, et al.
Journal of Applied Clinical Medical Physics|October 30, 2018
Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectivesNevin McVicar, Steven Thomas, Mitchell Liu, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|May 4, 2019
In Reply to RyuEmma M Dunne, Mitchell Liu
Practical Radiation Oncology|June 28, 2024
In Regard to Moore-Palhares et alJee Suk Chang, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|January 10, 2021
Postoperative Stereotactic Body Radiation Therapy, Then ObserveEmma M Dunne, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|December 20, 2018
A Kidney Conundrum: More or Less?Emma M Dunne, Mitchell Liu
Journal of Applied Clinical Medical Physics|May 30, 2007
PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysisMiao Zhang, Vitali Moiseenko, Mitchell Liu
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Segmental urethral dosimetry and urinary toxicity in patients with no urinary symptoms before permanent prostate brachytherapyCarys Thomas, Mira Keyes, Mitchell Liu, et al.
Radiation Oncology (London, England)|June 23, 2017
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastasesRosanna Yeung, Jeremy Hamm, Mitchell Liu, et al.
Annals of Translational Medicine|August 15, 2018
Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directionsEmma Maria Dunne, Ian Mark Fraser, Mitchell Liu
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 23, 2026
Response to "Re: O'Reilly et al. On CTV utilization in non-spine bone oligometastases treated with SABR"Sarah Baker, Emily O'Reilly, Emma M Dunne, et al.
Journal of Applied Clinical Medical Physics|October 30, 2018
Re-irradiation volumetric modulated arc therapy optimization based on cumulative biologically effective dose objectivesNevin McVicar, Steven Thomas, Mitchell Liu, et al.
Pageof 10